These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 8169855

  • 1. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
    Kost CK, Herzer WA, Li P, Jackson EK.
    J Pharmacol Exp Ther; 1994 Apr; 269(1):82-8. PubMed ID: 8169855
    [Abstract] [Full Text] [Related]

  • 2. Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats.
    Li P, Jackson EK.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):909-21. PubMed ID: 2557422
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats.
    Vyas SJ, Jackson EK.
    J Pharmacol Exp Ther; 1995 May; 273(2):768-77. PubMed ID: 7752079
    [Abstract] [Full Text] [Related]

  • 4. The inhibitory effect of angiotensin II on stimulus-induced release of cAMP is augmented in the genetically hypertensive rat kidney.
    Vyas SJ, Mi Z, Jackson EK.
    J Pharmacol Exp Ther; 1996 Oct; 279(1):114-9. PubMed ID: 8858983
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin II-induced renal vasoconstriction in genetic hypertension.
    Jackson EK, Herzer WA, Vyas SJ, Kost CK.
    J Pharmacol Exp Ther; 1999 Oct; 291(1):329-34. PubMed ID: 10490921
    [Abstract] [Full Text] [Related]

  • 6. Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: independence from hypertension and renal hemodynamic effects of angiotensin.
    Jackson EK, Herzer WA, Mi Z, Vyas SJ, Kost CK.
    J Pharmacol Exp Ther; 1999 Oct; 291(1):115-23. PubMed ID: 10490894
    [Abstract] [Full Text] [Related]

  • 7. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
    Haddad G, Garcia R.
    J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
    [Abstract] [Full Text] [Related]

  • 8. Characterization and hemodynamic implications of renal vascular angiotensin II receptors in SHR.
    Haddad G, Garcia R.
    J Mol Cell Cardiol; 1996 Feb; 28(2):351-61. PubMed ID: 8729067
    [Abstract] [Full Text] [Related]

  • 9. Effects of des-aspartate-angiotensin I on the actions of angiotensin III in the renal and mesenteric vasculature of normo- and hypertensive rats.
    Mustafa MR, Dharmani M, Kunheen NK, Sim MK.
    Regul Pept; 2004 Aug 15; 120(1-3):15-22. PubMed ID: 15177916
    [Abstract] [Full Text] [Related]

  • 10. Enhanced in vivo responsiveness of presynaptic angiotensin II receptor-mediated facilitation of vascular adrenergic neurotransmission in spontaneously hypertensive rats.
    Cline WH.
    J Pharmacol Exp Ther; 1985 Mar 15; 232(3):661-9. PubMed ID: 2983066
    [Abstract] [Full Text] [Related]

  • 11. Effects of deoxycorticosterone on renal vascular reactivity and flow-pressure curve in spontaneously hypertensive rats.
    Chamorro V, Moreno JM, Wangensteen R, Sainz J, Rodriguez-Gomez I, Osuna A, Vargas F.
    J Physiol Pharmacol; 2004 Mar 15; 55(1 Pt 1):17-26. PubMed ID: 15082864
    [Abstract] [Full Text] [Related]

  • 12. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
    Guidi E, Hollenberg NK.
    J Hypertens Suppl; 1986 Dec 15; 4(6):S480-2. PubMed ID: 11538668
    [Abstract] [Full Text] [Related]

  • 13. Evidence for a captopril-sensitive angiotensin converting enzyme in the hindquarter vasculature of SHR and WKY.
    Mueller SM, Cohen ML.
    Artery; 1985 Dec 15; 12(6):337-45. PubMed ID: 2996465
    [Abstract] [Full Text] [Related]

  • 14. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.
    Castro-Moreno P, Pardo JP, Hernández-Muñoz R, López-Guerrero JJ, Del Valle-Mondragón L, Pastelín-Hernández G, Ibarra-Barajas M, Villalobos-Molina R.
    Auton Autacoid Pharmacol; 2012 Oct 15; 32(3 Pt 4):61-9. PubMed ID: 22994939
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin II-induced changes in G-protein expression and resistance of renal microvessels in young genetically hypertensive rats.
    Vyas SJ, Blaschak CM, Chinoy MR, Jackson EK.
    Mol Cell Biochem; 2000 Sep 15; 212(1-2):121-9. PubMed ID: 11108143
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low concentrations of angiotensin II unmask vasoconstrictory alpha 2-adrenoceptors in isolated perfused kidneys of spontaneously hypertensive rats.
    Bohmann C, Rist W, Schollmeyer P, Rump LC.
    Cardiovasc Res; 1995 Dec 15; 30(6):857-65. PubMed ID: 8746199
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of Ang II and renal sympathetic nerve influence dopamine-and isoprenaline-induced renal haemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats.
    Abdulla MH, Sattar MA, Abdullah NA, Hazim AI, Anand Swarup KR, Rathore HA, Khan MA, Johns EJ.
    Auton Autacoid Pharmacol; 2008 Oct 15; 28(4):95-101. PubMed ID: 18778332
    [Abstract] [Full Text] [Related]

  • 20. Comparison of angiotensin II-induced blood pressure and structural changes in Fischer 344 and Wistar Kyoto rats.
    Blanc J, Lacolley P, Laurent S, Elghozi JL.
    Clin Exp Pharmacol Physiol; 2004 Jul 15; 31(7):466-73. PubMed ID: 15236636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.